{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:38:06Z","timestamp":1793036286576,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82151308"],"award-info":[{"award-number":["82151308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771176"],"award-info":[{"award-number":["81771176"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82150710558"],"award-info":[{"award-number":["82150710558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["6-OHDA"],"award-info":[{"award-number":["6-OHDA"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["PD 58\\u201361"],"award-info":[{"award-number":["PD 58\\u201361"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["10 \\u2013 15 years"],"award-info":[{"award-number":["10 \\u2013 15 years"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Journal of Traumatology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cjtee.2023.08.003","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T11:56:58Z","timestamp":1692964618000},"page":"125-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting the adenosine A2A receptor for neuroprotection and cognitive improvement in traumatic brain injury and Parkinson's disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Yan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Guo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Fan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjtee.2023.08.003_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11102-019-00957-9","article-title":"Traumatic brain injury: neuropathological, neurocognitive and neurobehavioral sequelae","volume":"22","author":"Pavlovic","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.cjtee.2023.08.003_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-3-319-57193-5_15","article-title":"Traumatic brain injury as a trigger of neurodegeneration","volume":"15","author":"Johnson","year":"2017","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.24121","article-title":"Traumatic brain injury may increase risk of young onset dementia","volume":"75","author":"Gardner","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrneurol.2013.29","article-title":"Chronic neuropathologies of single and repetitive TBI: substrates of dementia?","volume":"9","author":"Smith","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/(SICI)1098-1136(199610)18:2<152::AID-GLIA7>3.0.CO;2-2","article-title":"Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors","volume":"18","author":"Fiebich","year":"1996","journal-title":"Glia"},{"key":"10.1016\/j.cjtee.2023.08.003_bib6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jamaneurol.2018.0815","article-title":"Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans","volume":"75","author":"Barnes","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/HTR.0b013e3182585d06","article-title":"Centrum semiovale and corpus callosum integrity in relation to information processing speed in patients with severe traumatic brain injury","volume":"28","author":"Kourtidou","year":"2013","journal-title":"J\u00a0Head Trauma Rehabil"},{"key":"10.1016\/j.cjtee.2023.08.003_bib8","doi-asserted-by":"crossref","first-page":"e1248","DOI":"10.1212\/WNL.0000000000200041","article-title":"Cognitive outcome 1 year after mild traumatic brain injury: results from the TRACK-TBI study","volume":"98","author":"Schneider","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2340\/16501977-1182","article-title":"Long-term follow-up of patients with mild traumatic brain injury: a mixed-method study","volume":"45","author":"Ahman","year":"2013","journal-title":"J\u00a0Rehabil Med"},{"key":"10.1016\/j.cjtee.2023.08.003_bib10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/13803390490919245","article-title":"The effect of moderate to severe traumatic brain injury (TBI) on different aspects of memory: a selective review","volume":"27","author":"Vakil","year":"2005","journal-title":"J\u00a0Clin Exp Neuropsychol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13063-019-3526-x","article-title":"Executive function training in chronic traumatic brain injury patients: study protocol","volume":"20","author":"Krawczyk","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.cjtee.2023.08.003_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/neur.2020.0030","article-title":"Traumatic brain injury, abuse, and poor sustained attention in youth and young adults who previously experienced foster care","volume":"2","author":"Cusimano","year":"2021","journal-title":"Neurotrauma Rep"},{"key":"10.1016\/j.cjtee.2023.08.003_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s11682-018-9906-0","article-title":"Loss of white matter connections after severe traumatic brain injury (TBI) and its relationship to social cognition","volume":"13","author":"McDonald","year":"2019","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.cjtee.2023.08.003_bib14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/neu.2021.0374","article-title":"Neuroimaging correlates of depression after traumatic brain injury: a systematic review","volume":"39","author":"Medeiros","year":"2022","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.cjtee.2023.08.003_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.biopsych.2021.09.024","article-title":"Mental health consequences of traumatic brain injury","volume":"91","author":"Howlett","year":"2022","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.cjtee.2023.08.003_bib16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cjtee.2023.08.003_bib17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet Neurol"},{"issue":"5280","key":"10.1016\/j.cjtee.2023.08.003_bib18","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.273.5280.1399","article-title":"A\u00a0neostriatal habit learning system in humans","volume":"273","author":"Knowlton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.cjtee.2023.08.003_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.expneurol.2019.01.019","article-title":"Chronic treatment with galantamine rescues reversal learning in an attentional set-shifting test after experimental brain trauma","volume":"315","author":"Njoku","year":"2019","journal-title":"Exp Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jcph.980","article-title":"Effect of memantine on serum levels of neuron-specific enolase and on the Glasgow coma scale in patients with moderate traumatic brain injury","volume":"58","author":"Mokhtari","year":"2018","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib21","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1089\/neu.2020.7146","article-title":"Rivastigmine transdermal patch treatment for moderate to severe cognitive impairment in veterans with traumatic brain injury (RiVET study): a randomized clinical trial","volume":"38","author":"Brawman-Mintzer","year":"2021","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.cjtee.2023.08.003_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1755-5949.2010.00166.x","article-title":"Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data","volume":"17","author":"van Laar","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.cjtee.2023.08.003_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00002826-200211000-00002","article-title":"Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmine","volume":"25","author":"Richard","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/brain\/110.1.35","article-title":"Parkinson's disease. Cognitive changes in relation to treatment response","volume":"110","author":"Taylor","year":"1987","journal-title":"Brain"},{"key":"10.1016\/j.cjtee.2023.08.003_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/brain\/111.2.299","article-title":"'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa","volume":"111","author":"Gotham","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.cjtee.2023.08.003_bib27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF02245167","article-title":"L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction","volume":"107","author":"Lange","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.cjtee.2023.08.003_bib28","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1474-4422(16)30329-5","article-title":"Cognitive impairment in Parkinson's disease","volume":"16","author":"Majbour","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib30","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1111\/bph.13061","article-title":"MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway","volume":"172","author":"Zhu","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1471-4159.2011.07608.x","article-title":"Reduced calcium\/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice","volume":"120","author":"Moriguchi","year":"2012","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1358\/dnp.2003.16.9.829342","article-title":"The adenosine A(2A) receptor as an attractive target for Parkinson's disease treatment","volume":"16","author":"Chen","year":"2003","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.cjtee.2023.08.003_bib33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tins.2006.09.004","article-title":"Targeting adenosine A2A receptors in Parkinson's disease","volume":"29","author":"Schwarzschild","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.parkreldis.2008.12.006","article-title":"Adenosine, adenosine A2A antagonists, and Parkinson's disease","volume":"15","author":"Jenner","year":"2009","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.cjtee.2023.08.003_bib35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0165-6147(97)90660-X","article-title":"Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease","volume":"18","author":"Richardson","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1474-4422(11)70012-6","article-title":"Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial","volume":"10","author":"Hauser","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib37","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/157015909789152137","article-title":"Adenosine neuromodulation and traumatic brain injury","volume":"7","author":"Lusardi","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/jnc.15590","article-title":"Cerebrospinal fluid purinomics as a biomarker approach to predict outcome after severe traumatic brain injury","volume":"161","author":"Strogulski","year":"2022","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib39","doi-asserted-by":"crossref","unstructured":"Bell MJ, Kochanek PM, Carcillo JA, et\u00a0al. Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J Neurotrauma 198;15:163-170. https:\/\/doi.org\/10.1089\/neu.1998.15.163.","DOI":"10.1089\/neu.1998.15.163"},{"key":"10.1016\/j.cjtee.2023.08.003_bib40","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/jnc.14018","article-title":"Adenosine production by brain cells","volume":"141","author":"Jackson","year":"2017","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib41","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s41598-017-02505-6","article-title":"Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjtee.2023.08.003_bib42","first-page":"3666","volume":"vol. 176","author":"Carmo","year":"2019"},{"key":"10.1016\/j.cjtee.2023.08.003_bib43","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/brain\/awy351","article-title":"CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling","volume":"142","author":"Meng","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.cjtee.2023.08.003_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2016.05.040","article-title":"Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy","volume":"283","author":"Hu","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib45","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1212\/WNL.0b013e31821ccce4","article-title":"Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease","volume":"76","author":"Ramlackhansingh","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017338","article-title":"Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients","volume":"6","author":"Mishina","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cjtee.2023.08.003_bib47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2014.05.030","article-title":"Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b","volume":"69","author":"Villar-Menendez","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.cjtee.2023.08.003_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neurobiolaging.2017.08.010","article-title":"Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease","volume":"60","author":"Horgusluoglu-Moloch","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cjtee.2023.08.003_bib49","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/mp.2014.182","article-title":"Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory","volume":"20","author":"Li","year":"2015","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.cjtee.2023.08.003_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nlm.2006.05.004","article-title":"Working memory deficits in transgenic rats overexpressing human adenosine A2A receptors in the brain","volume":"87","author":"Gimenez-Llort","year":"2007","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib51","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/epi.13044","article-title":"Genetic variation in the adenosine regulatory cycle is associated with posttraumatic epilepsy development","volume":"56","author":"Diamond","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.cjtee.2023.08.003_bib52","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.jcbfm.9600218","article-title":"Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury","volume":"26","author":"Kochanek","year":"2006","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.eplepsyres.2010.06.001","article-title":"Adenosine A1 receptor gene variants associated with post-traumatic seizures after severe TBI","volume":"90","author":"Wagner","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.cjtee.2023.08.003_bib54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.seizure.2017.02.002","article-title":"Genetic biomarkers of posttraumatic epilepsy: a systematic review","volume":"46","author":"Cotter","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.cjtee.2023.08.003_bib55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/SHK.0b013e318231ee2e","article-title":"Increased neutrophil adenosine a3 receptor expression is associated with hemorrhagic shock and injury severity in trauma patients","volume":"36","author":"Bulger","year":"2011","journal-title":"Shock"},{"key":"10.1016\/j.cjtee.2023.08.003_bib56","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1126\/science.1132559","article-title":"ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors","volume":"314","author":"Chen","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.cjtee.2023.08.003_bib57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12974-020-02009-7","article-title":"Adenosine A3 receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury","volume":"17","author":"Farr","year":"2020","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.cjtee.2023.08.003_bib58","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pbb.2006.05.027","article-title":"Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats","volume":"84","author":"Aguiar","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.cjtee.2023.08.003_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.0022-3042.2001.00694.x","article-title":"Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease","volume":"80","author":"Ikeda","year":"2002","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(02)00069-1","article-title":"Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice","volume":"322","author":"Xu","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.cjtee.2023.08.003_bib61","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib62","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.22630","article-title":"Adenosine A2A receptor gene disruption protects in an alpha-synuclein model of Parkinson's disease","volume":"71","author":"Kachroo","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib63","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2016.05.040","article-title":"Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy","volume":"283","author":"Hu","year":"2016","journal-title":"Exp Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fnins.2018.00301","article-title":"Chronic caffeine treatment protects against alpha-synucleinopathy by reestablishing autophagy activity in the mouse striatum","volume":"12","author":"Luan","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib65","first-page":"718","article-title":"Adenosine A2A receptors modulate alpha-synuclein aggregation and toxicity","volume":"27","author":"Ferreira","year":"2017","journal-title":"Cerebr Cortex"},{"key":"10.1016\/j.cjtee.2023.08.003_bib66","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/nn.4648","article-title":"alpha-synuclein interacts with PrP(C) to induce cognitive impairment through mGluR5 and NMDAR2B","volume":"20","author":"Ferreira","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib67","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.expneurol.2012.01.022","article-title":"Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease","volume":"234","author":"Sonsalla","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105080","article-title":"Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury","volume":"145","author":"van Vliet","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.cjtee.2023.08.003_bib69","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.3390\/ijms23179628","article-title":"Glutamate neurotoxicity and destruction of the blood-brain barrier: key pathways for the development of neuropsychiatric consequences of TBI and their potential treatment strategies","volume":"23","author":"Gruenbaum","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/neu.2020.7545","article-title":"Permeability of the blood-brain barrier after traumatic brain injury: radiological considerations","volume":"39","author":"Amoo","year":"2022","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.cjtee.2023.08.003_bib71","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/WCO.0000000000000763","article-title":"Wallerian degeneration as a therapeutic target in traumatic brain injury","volume":"32","author":"Koliatsos","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib72","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/jnnp-2017-317557","article-title":"Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia","volume":"90","author":"Graham","year":"2019","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cjtee.2023.08.003_bib73","first-page":"12","article-title":"The meningeal transcriptional response to traumatic brain injury and aging","volume":"3","author":"Bolte","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.cjtee.2023.08.003_bib74","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2174\/1570159X18666200207120949","article-title":"Role of nuclear factor kappa B (NF-kappaB) signalling in neurodegenerative diseases: an mechanistic approach","volume":"18","author":"Singh","year":"2020","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-065X.2011.01042.x","article-title":"Deregulated inflammasome signaling in disease","volume":"243","author":"Lamkanfi","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cjtee.2023.08.003_bib76","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jocn.2022.03.009","article-title":"P2X4 inhibition reduces microglia inflammation and apoptosis by NLRP3 and improves nervous system defects in rat brain trauma model","volume":"99","author":"He","year":"2022","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121352","article-title":"NLRP3 inflammasome in traumatic brain injury: its implication in the disease pathophysiology and potential as a therapeutic target","volume":"314","author":"Chakraborty","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib78","first-page":"46","article-title":"GSK-3beta, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Martin","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib79","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1471-4159.2011.07610.x","article-title":"STAT3 signaling after traumatic brain injury","volume":"120","author":"Oliva","year":"2012","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib80","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004647-200203000-00010","article-title":"Differential activation of mitogen-activated protein kinase pathways after traumatic brain injury in the rat hippocampus","volume":"22","author":"Otani","year":"2002","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib81","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1015791","article-title":"Targeting Nrf2-mediated oxidative stress response in traumatic brain injury: therapeutic perspectives of phytochemicals","volume":"2022","author":"Wu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.cjtee.2023.08.003_bib82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/ijms24010199","article-title":"Nrf2 activation: involvement in central nervous system traumatic injuries. A promising therapeutic target of natural compounds","volume":"24","author":"Silvestro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/cells9010245","article-title":"RhoA-ROCK signaling as a therapeutic target in traumatic brain injury","volume":"9","author":"Mulherkar","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cjtee.2023.08.003_bib84","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fnins.2018.00628","article-title":"HMGB1: a common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction","volume":"12","author":"Paudel","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib85","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12974-020-01778-5","article-title":"The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target","volume":"17","author":"O'Brien","year":"2020","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.cjtee.2023.08.003_bib86","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","article-title":"Neuroimmunology of traumatic brain injury: time for a paradigm shift","volume":"95","author":"Jassam","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.cjtee.2023.08.003_bib87","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/neu.2015.4373","article-title":"Glutamate neurotransmission in rodent models of traumatic brain injury","volume":"34","author":"Dorsett","year":"2017","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.cjtee.2023.08.003_bib88","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2016.02.006","article-title":"Therapies targeting lipid peroxidation in traumatic brain injury","volume":"1640","author":"Anthonymuthu","year":"2016","journal-title":"Brain Res"},{"key":"10.1016\/j.cjtee.2023.08.003_bib89","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1523\/JNEUROSCI.0268-10.2010","article-title":"Local glutamate level dictates adenosine A2A receptor regulation of neuroinflammation and traumatic brain injury","volume":"30","author":"Dai","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib90","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1038\/jcbfm.2013.127","article-title":"Adenosine A2A receptor deficiency alleviates blast-induced cognitive dysfunction","volume":"33","author":"Ning","year":"2013","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib91","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/clinchem\/47.8.1458","article-title":"Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries","volume":"47","author":"Zhang","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib92","first-page":"254","article-title":"Different effects of adenosine A2A receptors in the models of traumatic brain injury and peripheral tissue injury","volume":"60","author":"Dai","year":"2008","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.cjtee.2023.08.003_bib93","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.expneurol.2008.09.012","article-title":"Genetic inactivation of adenosine A2A receptors attenuates acute traumatic brain injury in the mouse cortical impact model","volume":"215","author":"Li","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib94","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.neuroscience.2007.11.020","article-title":"Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model","volume":"151","author":"Li","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.cjtee.2023.08.003_bib95","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/sj.bjp.0704712","article-title":"Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes","volume":"136","author":"Marchi","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib96","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0028-3908(03)00156-4","article-title":"Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices","volume":"45","author":"Marcoli","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib97","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.neuropharm.2004.06.022","article-title":"Glutamate efflux from human cerebrocortical slices during ischemia: vesicular-like mode of glutamate release and sensitivity to A(2A) adenosine receptor blockade","volume":"47","author":"Marcoli","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib98","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hipo.20894","article-title":"Enhancement of AMPA currents and GluR1 membrane expression through PKA-coupled adenosine A(2A) receptors","volume":"22","author":"Dias","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.cjtee.2023.08.003_bib99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/glia.10100","article-title":"A\u00a0new neuromodulatory pathway with a glial contribution mediated via A(2a) adenosine receptors","volume":"39","author":"Nishizaki","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.cjtee.2023.08.003_bib100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bbrc.2018.03.060","article-title":"Adenosine A2A receptor inhibition restores the normal transport of endothelial glutamate transporters in the brain","volume":"498","author":"Bai","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cjtee.2023.08.003_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136431","article-title":"High glutamate concentration reverses the inhibitory effect of microglial adenosine 2A receptor on NLRP3 inflammasome assembly and activation","volume":"769","author":"Du","year":"2022","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.cjtee.2023.08.003_bib102","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s11064-019-02895-1","article-title":"PKC mediates LPS-induced IL-1beta expression and participates in the pro-inflammatory effect of A2AR under high glutamate concentrations in mouse microglia","volume":"44","author":"Fu","year":"2019","journal-title":"Neurochem Res"},{"key":"10.1016\/j.cjtee.2023.08.003_bib103","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1471-4159.2010.06716.x","article-title":"Adenosine A2A receptors in both bone marrow cells and non-bone marrow cells contribute to traumatic brain injury","volume":"113","author":"Dai","year":"2010","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib104","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/rns.2011.020","article-title":"Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury","volume":"22","author":"Dai","year":"2011","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib105","doi-asserted-by":"crossref","first-page":"13272","DOI":"10.1523\/JNEUROSCI.3337-11.2011","article-title":"Adenosine receptor signaling modulates permeability of the blood-brain barrier","volume":"31","author":"Carman","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib106","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11302-005-0649-1","article-title":"Neuroprotection by adenosine in the brain: from A(1) receptor activation to A (2A) receptor blockade","volume":"1","author":"Cunha","year":"2005","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.cjtee.2023.08.003_bib107","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pneurobio.2007.09.002","article-title":"Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and \"fine tuning\" modulation","volume":"83","author":"Chen","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib108","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2174\/138161208784480126","article-title":"Modulation of ischemic brain injury and neuroinflammation by adenosine A2A receptors","volume":"14","author":"Chen","year":"2008","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.cjtee.2023.08.003_bib109","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/SHK.0000000000001170","article-title":"Reduction in blood glutamate levels combined with the genetic inactivation of A2AR significantly alleviate traumatic brain injury-induced acute lung injury","volume":"51","author":"Bai","year":"2019","journal-title":"Shock"},{"key":"10.1016\/j.cjtee.2023.08.003_bib110","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1016\/j.wneu.2019.01.164","article-title":"Time-dependent bidirectional neuroprotection by adenosine 2A receptor in experimental traumatic brain injury","volume":"125","author":"Velayutham","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.cjtee.2023.08.003_bib111","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.neuroscience.2006.05.014","article-title":"Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells","volume":"141","author":"Li","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.cjtee.2023.08.003_bib112","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(99)00011-8","article-title":"Distribution, biochemistry and function of striatal adenosine A2A receptors","volume":"59","author":"Svenningsson","year":"1999","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib113","doi-asserted-by":"crossref","first-page":"46741","DOI":"10.1074\/jbc.M306451200","article-title":"Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer","volume":"278","author":"Canals","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib114","doi-asserted-by":"crossref","first-page":"18091","DOI":"10.1074\/jbc.M107731200","article-title":"Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors","volume":"277","author":"Hillion","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib115","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/01.WNL.0000095206.44418.5C","article-title":"Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease","volume":"61","author":"Fuxe","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib116","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nn.2592","article-title":"Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors","volume":"13","author":"Higley","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib117","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(02)02301-4","article-title":"Adenosine A2A receptors inhibit the N-methyl-D-aspartate component of excitatory synaptic currents in rat striatal neurons","volume":"451","author":"Gerevich","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib118","doi-asserted-by":"crossref","first-page":"11940","DOI":"10.1073\/pnas.172393799","article-title":"Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function","volume":"99","author":"Ferre","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjtee.2023.08.003_bib119","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/sj.npp.1300444","article-title":"Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats","volume":"29","author":"Coccurello","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib120","doi-asserted-by":"crossref","first-page":"10414","DOI":"10.1523\/JNEUROSCI.3660-05.2005","article-title":"Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice","volume":"25","author":"Kachroo","year":"2005","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib121","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1523\/JNEUROSCI.5844-09.2010","article-title":"Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists","volume":"30","author":"Lerner","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib122","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1476-5381.2010.00723.x","article-title":"Adenosine-cannabinoid receptor interactions. Implications for striatal function","volume":"160","author":"Ferre","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib123","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/01.WNL.0000095205.33940.99","article-title":"Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function","volume":"61","author":"Rosin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib124","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2005.01.054","article-title":"Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus","volume":"133","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.cjtee.2023.08.003_bib125","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","article-title":"Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers","volume":"26","author":"Ciruela","year":"2006","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib126","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1101\/lm.2136011","article-title":"Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning","volume":"18","author":"Wei","year":"2011","journal-title":"Learn Mem"},{"key":"10.1016\/j.cjtee.2023.08.003_bib127","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2009.09.082","article-title":"Preferential enhancement of working memory in mice lacking adenosine A(2A) receptors","volume":"1303","author":"Zhou","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.cjtee.2023.08.003_bib128","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1523\/JNEUROSCI.1525-08.2008","article-title":"Nucleus accumbens adenosine A2A receptors regulate exertion of effort by acting on the ventral striatopallidal pathway","volume":"28","author":"Mingote","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cjtee.2023.08.003_bib129","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.biopsych.2013.05.003","article-title":"Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain","volume":"75","author":"Wei","year":"2014","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.cjtee.2023.08.003_bib130","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/npp.2015.227","article-title":"Optogenetic activation of adenosine A2A receptor signaling in the dorsomedial striatopallidal neurons suppresses goal-directed behavior","volume":"41","author":"Li","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib131","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-013-3158-x","article-title":"Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex","volume":"230","author":"Kadowaki Horita","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.cjtee.2023.08.003_bib132","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuropharm.2016.07.012","article-title":"An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models","volume":"110","author":"Ko","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib133","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/mp.2015.115","article-title":"A2A adenosine receptor deletion is protective in a mouse model of Tauopathy","volume":"21","author":"Laurent","year":"2016","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.cjtee.2023.08.003_bib134","doi-asserted-by":"crossref","first-page":"e1123","DOI":"10.1038\/tp.2017.98","article-title":"Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation","volume":"7","author":"Zhao","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.cjtee.2023.08.003_bib135","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1111\/jcmm.15361","article-title":"A2A R inhibition in alleviating spatial recognition memory impairment after TBI is associated with improvement in autophagic flux in RSC","volume":"24","author":"Zeng","year":"2020","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.cjtee.2023.08.003_bib136","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2012.8","article-title":"Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation","volume":"18","author":"Batalha","year":"2013","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.cjtee.2023.08.003_bib137","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/npp.2015.25","article-title":"Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer's disease","volume":"40","author":"Lante","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib138","doi-asserted-by":"crossref","DOI":"10.1038\/srep31493","article-title":"The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function","volume":"6","author":"Batalha","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjtee.2023.08.003_bib139","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41419-018-0316-4","article-title":"Impaired autophagic flux is associated with the severity of trauma and the role of A2AR in brain cells after traumatic brain injury","volume":"9","author":"Zeng","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.cjtee.2023.08.003_bib140","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cjtee.2023.08.003_bib141","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/01.WNL.0000046523.05125.87","article-title":"Caffeine, postmenopausal estrogen, and risk of Parkinson's disease","volume":"60","author":"Ascherio","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib142","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.ejcn.1602788","article-title":"Prospective study of coffee consumption and risk of Parkinson's disease","volume":"62","author":"Saaksjarvi","year":"2008","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.cjtee.2023.08.003_bib143","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-nutr-071816-064941","article-title":"Coffee, caffeine, and health outcomes: an umbrella review","volume":"37","author":"Grosso","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.cjtee.2023.08.003_bib144","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib145","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/ggi.12123","article-title":"Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease","volume":"14","author":"Qi","year":"2014","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.cjtee.2023.08.003_bib146","first-page":"505","article-title":"Associations of lower caffeine intake and plasma urate levels with idiopathic Parkinson's disease in the Harvard biomarkers study","volume":"10","author":"Bakshi","year":"2020","journal-title":"J\u00a0Parkinsons Dis"},{"key":"10.1016\/j.cjtee.2023.08.003_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/srep15492","article-title":"Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson's disease","volume":"5","author":"Kumar","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjtee.2023.08.003_bib148","doi-asserted-by":"crossref","first-page":"e3428","DOI":"10.1212\/WNL.0000000000010863","article-title":"Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers: a metabolomic study","volume":"95","author":"Crotty","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib149","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-2009-1071","article-title":"Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice","volume":"17","author":"Cao","year":"2009","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.cjtee.2023.08.003_bib150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2015.10.031","article-title":"Purinergic receptors as potential therapeutic targets in Alzheimer's disease","volume":"104","author":"Woods","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib151","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0091-3057(03)00171-0","article-title":"The effects of habitual caffeine use on cognitive change: a longitudinal perspective","volume":"75","author":"Vanboxtel","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.cjtee.2023.08.003_bib152","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/aje\/kwf074","article-title":"Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging","volume":"156","author":"Lindsay","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib153","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ejcn.1602495","article-title":"Coffee consumption is inversely associated with cognitive decline in elderly European men: the FINE Study","volume":"61","author":"van Gelder","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.cjtee.2023.08.003_bib154","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-2009-0920","article-title":"Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study","volume":"16","author":"Eskelinen","year":"2009","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.cjtee.2023.08.003_bib155","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hup.218","article-title":"Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups","volume":"15","author":"Hameleers","year":"2000","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib156","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.wnl.0000266670.35219.0c","article-title":"The neuroprotective effects of caffeine: a prospective population study (the Three City Study)","volume":"69","author":"Ritchie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.cjtee.2023.08.003_bib157","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.parkreldis.2018.02.016","article-title":"Association of coffee consumption and non-motor symptoms in drug-naive, early-stage Parkinson's disease","volume":"50","author":"Cho","year":"2018","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.cjtee.2023.08.003_bib158","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00213-021-06054-9","article-title":"Caffeine and attentional control: improved and impaired performance in healthy older adults and Parkinson's disease according to task demands","volume":"239","author":"Sharma","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.cjtee.2023.08.003_bib159","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/sj.jcbfm.9600539","article-title":"Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans","volume":"28","author":"Sachse","year":"2008","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.toxlet.2018.11.004","article-title":"Caffeine attenuates brain injury but increases mortality induced by high-intensity blast wave exposure","volume":"301","author":"Ning","year":"2019","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.cjtee.2023.08.003_bib161","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cjtee.2015.10.003","article-title":"Chronic caffeine exposure attenuates blast-induced memory deficit in mice","volume":"18","author":"Ning","year":"2015","journal-title":"Chin J Traumatol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib162","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.expneurol.2011.12.026","article-title":"Caffeine prevents acute mortality after TBI in rats without increased morbidity","volume":"234","author":"Lusardi","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.cjtee.2023.08.003_bib163","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.biopsych.2017.07.017","article-title":"The corticostriatal adenosine A2A receptor controls maintenance and retrieval of spatial working memory","volume":"83","author":"Li","year":"2018","journal-title":"Biol Psychiatr"}],"container-title":["Chinese Journal of Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1008127523000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1008127523000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:29:26Z","timestamp":1778794166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1008127523000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":163,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1008127523000871"],"URL":"https:\/\/doi.org\/10.1016\/j.cjtee.2023.08.003","relation":{},"ISSN":["1008-1275"],"issn-type":[{"value":"1008-1275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the adenosine A2A receptor for neuroprotection and cognitive improvement in traumatic brain injury and Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Chinese Journal of Traumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjtee.2023.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Production and hosting by Elsevier B.V. on behalf of Chinese Medical Association.","name":"copyright","label":"Copyright"}]}}